Human protective monoclonal antibodies against the HA stem of group 2 HAs derived from an H3N2 virus-infected human

•We isolated two hetero-protective anti-HA stem antibodies.•These antibodies suppress group 2 influenza A viruses in vitro and in vivo.•They recognize epitopes on the HA stem. Broadly reactive human monoclonal antibodies against the HA stem of influenza A virus are being developed as therapeutic age...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of infection Vol. 76; no. 2; pp. 177 - 185
Main Authors Yamayoshi, Seiya, Ito, Mutsumi, Uraki, Ryuta, Sasaki, Tadahiro, Ikuta, Kazuyoshi, Kawaoka, Yoshihiro
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.02.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:•We isolated two hetero-protective anti-HA stem antibodies.•These antibodies suppress group 2 influenza A viruses in vitro and in vivo.•They recognize epitopes on the HA stem. Broadly reactive human monoclonal antibodies against the HA stem of influenza A virus are being developed as therapeutic agents as well as to understand the epitopes that are essential for a universal influenza virus vaccine. We isolated and characterized two hetero-reactive human monoclonal antibodies from an H3N2 virus-infected human. These antibodies, which are predominantly bound to the HA stem of group 2 HAs, used IGHV3-66 and IGHV4-38-2 germline genes, respectively. They possessed in vitro neutralizing ability, and in vivo protective efficacy against lethal infection with H3N2 or H7N9 virus. Escape mutations revealed that one of the protective antibodies recognized the α-helix A of HA2, and the other recognized the C-terminal portion of the fusion peptide and the β-sheet that precedes the α-helix A of HA2. Of many human protective monoclonal antibodies against the HA stem, two human protective monoclonal antibodies were isolated in this study that predominantly recognize epitopes on the HA stem of group 2 and use unique IGHV3-66 and IGHV4-38-2 germline genes.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
S.Y. and Y.K. designed the study. S.Y., M.I., and R.U. performed the experiments. S.Y., M.I., R.U., and K.Y. analyzed the data. T.S. and K.I. assisted with the experiments. S.Y. and Y.K. wrote the manuscript. All authors reviewed and approved the manuscript.
Author contributions
ISSN:0163-4453
1532-2742
1532-2742
DOI:10.1016/j.jinf.2017.12.004